Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder

Completed · Phase 4

Conditions studied: Body Dysmorphic Disorder

In brief

The purpose of this study is to assess the usefulness of a medication (Levetiracetam) for people with body dysmorphic disorder.

Key facts

Study ID
NCT00265109
Run by
Butler Hospital
People needed
17
Starts
2004-12-01
Expected to finish
2008-01-01
Last updated by the study team
2019-08-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.